Growing evidence is showing that psychedelics can improve mental health and change personality, and even political perspective in an enduring way. But are these changes always desirable for the individual and for society?
Come and meet Dr Robin Carhart-Harris who heads the Psychedelic Research Group at Imperial College London, where he has designed a number of pioneering brain imaging studies with psychedelic drugs such as psilocybin (magic mushrooms), LSD, MDMA (ecstasy) and DMT (ayahuasca), plus a clinical trial of psilocybin for treatment resistant depression.
Three of his papers ranked within the top 100 most impactful scientific papers of the year, over the last two years. Robin’s research has been profiled by the Independent, New Scientist and Wired magazine, and featured in a recent podcast with Russell Brand and a popular TEDx talk.